Sign in

CIK 0000899923 · Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
870494517
Phone
801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 8-K Event Executive or director change
  9. 10-Q Report Quarterly Report
  10. 8-K Event Other events
  11. 8-K Event Results of operations
  12. 4 Grant or award Chief Legal & Corp Strategy acquired 39,370 shares (grant or award)
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. 8-K Event Material agreement · Regulation FD disclosure
  15. 8-K Event Executive or director change
  16. 4 Shares withheld for taxes Chief Financial Officer gave up 2,555 shares (to pay taxes)
  17. 4 Insider Changes in Ownership
  18. 4 Grant or award EVP, Commercial acquired 257,731 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 8-K Event Executive or director change · Regulation FD disclosure

Page 1 of 104 · 2,077 filings